Back

Arcturus Therapeutics Holdings Quote, Financials, Valuation and Earnings

This trade could move overnight Thursday!

Access my free presentation on these overnight trades right here

Sell

ARCT
Arcturus Therapeutics Holdings

Last Price:

26.53

Seasonality Move:

34.84%

7 Day Trial

ALL ACCESS PASS

$ 7

America's Final Republican President

Click here to see his 2024 election prediction.

Arcturus Therapeutics Holdings Price Quote

$26.53

-0.02 (1.38%)

(Updated: April 27, 2024 at 5:53 AM ET)

Arcturus Therapeutics Holdings Key Stats

Sell

Arcturus Therapeutics Holdings (ARCT) is a Sell

Day range:

$25.84 - $26.86

52-week range:

$17.52 - $43.81

Dividend yield:

P/E ratio:

0.00

P/S ratio:

4.51

P/B ratio:

2.57%

Volume:

272.4K

Avg. volume:

520.7K

1-year change:

-0.38%

Market cap:

$714.6M

Revenue:

$157.7M

EPS:

$-1.16

How Much Does Arcturus Therapeutics Holdings Make?

How Much Are Arcturus Therapeutics Holdings's Sales Annually?
ARCT Revenues are $157.7M
How Much Profit Does Arcturus Therapeutics Holdings's Make A Year?
ARCT net income is -$29.7M

Is Arcturus Therapeutics Holdings Growing As A Company?

What Is Arcturus Therapeutics Holdings's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.84%
What Is Arcturus Therapeutics Holdings's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%

Arcturus Therapeutics Holdings Stock Price Performance

Did Arcturus Therapeutics Holdings Stock Go Up Last Month?
Arcturus Therapeutics Holdings share price went down by -17.37% last month
Did ARCT's Share Price Rise Over The Last Year?
ARCT share price fell by -0.38% over the past 1 year

What Is Arcturus Therapeutics Holdings 52-Week High & Low?

What Is Arcturus Therapeutics Holdings’s 52-Week High Share Price?
Arcturus Therapeutics Holdings has traded as high as $43.81 over the past 52 weeks
What Is Arcturus Therapeutics Holdings’s 52-Week Low Share Price?
Arcturus Therapeutics Holdings has traded as low as $17.52 over the past 52 weeks

Arcturus Therapeutics Holdings Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Arcturus Therapeutics Holdings?

How Much Debt Does Arcturus Therapeutics Holdings Have?
Total long term debt quarterly is $0
How Much Cash Does Arcturus Therapeutics Holdings Have?
Cash and short term investments quarterly total is $292M
What Is Arcturus Therapeutics Holdings’s Book Value Per Share?
Book value per share is 10.38

Is Arcturus Therapeutics Holdings Cash Flow Positive?

What Is ARCT Cash Flow From Operations?
Cash flow from operations (TTM) is -$18.1M
What Is Arcturus Therapeutics Holdings’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$24.1M
What Is Arcturus Therapeutics Holdings’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$2.9M

Arcturus Therapeutics Holdings Return On Invested Capital

Is Management Doing A Good Job?
ARCT return on invested capital is -9.75%
What Is Arcturus Therapeutics Holdings Return On Assets?
ROA measures how assets are converting to revenues and is -6.64%
What Is ARCT Return On Equity?
ROE is a measure of profitability and is -10.3%

Arcturus Therapeutics Holdings Earnings Date & Stock Price

What Is Arcturus Therapeutics Holdings's Stock Price Today?
A single share of ARCT can be purchased today for 26.55
What Is Arcturus Therapeutics Holdings’s Stock Symbol?
Arcturus Therapeutics Holdings trades on the nasdaq under the ticker symbol: ARCT
When Is Arcturus Therapeutics Holdings’s Next Earnings Date?
The next quarterly earnings date for Arcturus Therapeutics Holdings is scheduled on May 9, 2024
When Is ARCT's next ex-dividend date?
Arcturus Therapeutics Holdings's next ex-dividend date is May 15, 2020
How To Buy Arcturus Therapeutics Holdings Stock?
You can buy Arcturus Therapeutics Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Arcturus Therapeutics Holdings Competitors

Who Are Arcturus Therapeutics Holdings's Competitors?
Below is a list of companies who compete with Arcturus Therapeutics Holdings or are related in some way:
- AIM ImmunoTech Inc (AIM)
- Armata Pharmaceuticals Inc (ARMP)
- Perspective Therapeutics Inc (CATX)
- Electromed Inc (ELMD)
- Protalix BioTherapeutics Inc (PLX)

Arcturus Therapeutics Holdings Dividend Yield